Free Trial

Morgan Stanley (NYSE:MS) Receives Average Recommendation of "Moderate Buy" from Brokerages

Morgan Stanley logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Moderate Buy consensus from 19 analysts with an average 12‑month price target of $187.14; several firms raised targets (Barclays to $219) while others adjusted ratings (Evercore cut to hold, Wall Street Zen upgraded to buy).
  • Morgan Stanley advanced its MSBT spot Bitcoin ETF registration, disclosing $1M seed capital, a planned NYSE Arca listing and custodial partners (Coinbase and BNY Mellon), which could drive fee revenue and client asset flows.
  • The firm beat quarterly expectations (EPS $2.68 vs. $2.28 expected; revenue $17.90B, +10.3% YoY) and pays a $1.00 quarterly dividend (~2.5% yield), but it has limited redemptions in a private‑credit vehicle and flagged rising default/liquidity risks that could pressure asset‑management stability.
  • Five stocks to consider instead of Morgan Stanley.

Morgan Stanley (NYSE:MS - Get Free Report) has been given an average recommendation of "Moderate Buy" by the nineteen analysts that are currently covering the firm, MarketBeat reports. Eleven investment analysts have rated the stock with a hold rating, six have given a buy rating and two have given a strong buy rating to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $187.1429.

Several research firms have weighed in on MS. Barclays lifted their price objective on Morgan Stanley from $183.00 to $219.00 and gave the company an "overweight" rating in a research report on Monday, January 5th. Wall Street Zen upgraded Morgan Stanley from a "hold" rating to a "buy" rating in a research note on Friday, January 23rd. JPMorgan Chase & Co. lifted their price target on Morgan Stanley from $173.00 to $179.00 and gave the company a "neutral" rating in a research report on Tuesday, March 10th. Evercore cut Morgan Stanley from a "strong-buy" rating to a "hold" rating in a research note on Thursday, February 5th. Finally, BNP Paribas Exane increased their price objective on Morgan Stanley from $170.00 to $195.00 in a report on Friday, January 16th.

Check Out Our Latest Report on Morgan Stanley

Morgan Stanley News Summary

Here are the key news stories impacting Morgan Stanley this week:

  • Positive Sentiment: Morgan Stanley formally advanced its spot Bitcoin ETF registration (ticker MSBT), disclosing $1M seed capital, planned NYSE Arca listing, custodial partners (Coinbase/BNY Mellon) and named authorized participants — a potential new product that could bring fee revenue, increase client asset flows and reinforce MS’s digital-asset positioning. Morgan Stanley advances MSBT Bitcoin ETF with amended SEC filing
  • Neutral Sentiment: MS research is publishing macro downside scenarios (e.g., elevated European gas risk and earlier ECB hikes) and revised rate‑cut timing — these calls can drive market volatility and trading flows that affect MS’s trading & principal revenues but are not direct corporate fundamentals. Europe gas refill risks rise; MS flags €90 TTF scenario
  • Negative Sentiment: Morgan Stanley limited redemptions in a private‑credit vehicle and publicly flagged rising default/liquidity risk in parts of private credit — a near‑term negative for asset‑management fee stability, client confidence and potential reputational risk if outflows/credit losses broaden. Investors may be re‑pricing wealth & asset‑management exposure. Morgan Stanley Tests Private Credit Liquidity As AI Risks Surface

Morgan Stanley Trading Up 1.8%

NYSE:MS opened at $161.47 on Friday. The company has a 50-day moving average price of $173.36 and a 200-day moving average price of $168.43. The stock has a market cap of $256.39 billion, a price-to-earnings ratio of 15.81, a P/E/G ratio of 1.27 and a beta of 1.20. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 3.39. Morgan Stanley has a 12 month low of $94.33 and a 12 month high of $192.68.

Morgan Stanley (NYSE:MS - Get Free Report) last announced its quarterly earnings results on Thursday, January 15th. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.28 by $0.40. Morgan Stanley had a net margin of 14.09% and a return on equity of 16.78%. The company had revenue of $17.90 billion for the quarter, compared to analysts' expectations of $17.69 billion. During the same quarter in the previous year, the company earned $2.22 earnings per share. Morgan Stanley's quarterly revenue was up 10.3% on a year-over-year basis. Equities analysts predict that Morgan Stanley will post 8.56 EPS for the current year.

Morgan Stanley Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, February 13th. Stockholders of record on Friday, January 30th were given a $1.00 dividend. The ex-dividend date of this dividend was Friday, January 30th. This represents a $4.00 dividend on an annualized basis and a dividend yield of 2.5%. Morgan Stanley's dividend payout ratio is currently 39.18%.

Insider Buying and Selling

In other Morgan Stanley news, insider Andrew M. Saperstein sold 30,330 shares of the company's stock in a transaction dated Tuesday, January 20th. The shares were sold at an average price of $183.62, for a total value of $5,569,194.60. Following the sale, the insider owned 280,481 shares in the company, valued at approximately $51,501,921.22. This represents a 9.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Michael A. Pizzi sold 20,000 shares of the firm's stock in a transaction that occurred on Tuesday, January 20th. The shares were sold at an average price of $184.55, for a total transaction of $3,691,000.00. Following the transaction, the insider directly owned 127,872 shares of the company's stock, valued at $23,598,777.60. This represents a 13.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 129,191 shares of company stock worth $23,736,506 over the last 90 days. Corporate insiders own 0.19% of the company's stock.

Institutional Trading of Morgan Stanley

A number of hedge funds have recently made changes to their positions in the stock. Purpose Unlimited Inc. purchased a new stake in shares of Morgan Stanley in the 4th quarter worth approximately $25,000. Cornerstone Planning LLC purchased a new position in Morgan Stanley during the fourth quarter valued at $3,618,000. Rockefeller Capital Management L.P. boosted its holdings in Morgan Stanley by 17.6% in the fourth quarter. Rockefeller Capital Management L.P. now owns 429,669 shares of the financial services provider's stock worth $76,279,000 after acquiring an additional 64,401 shares in the last quarter. World Investment Advisors boosted its holdings in Morgan Stanley by 34.9% in the fourth quarter. World Investment Advisors now owns 28,138 shares of the financial services provider's stock worth $4,995,000 after acquiring an additional 7,272 shares in the last quarter. Finally, Nalls Sherbakoff Group LLC purchased a new stake in shares of Morgan Stanley in the fourth quarter worth $125,000. 84.19% of the stock is owned by institutional investors.

Morgan Stanley Company Profile

(Get Free Report)

Morgan Stanley NYSE: MS is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company's chief executive and chairman in recent years.

The firm's primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.

Read More

Analyst Recommendations for Morgan Stanley (NYSE:MS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Morgan Stanley Right Now?

Before you consider Morgan Stanley, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Morgan Stanley wasn't on the list.

While Morgan Stanley currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines